Skip to content

U.S. Health Policy Shifts Gears: Kennedy Jr. Initiates a Pivotal Moment with His Critique on Corona Vaccines

Health Overhaul by Robert F. Kennedy Jr.: US Health Bodies Face Rigorous Examination Over Corruption Allegations and Vaccine Issues

US health policy under fire: Kennedy Jr. initiates a significant shift with Corona vaccine...
US health policy under fire: Kennedy Jr. initiates a significant shift with Corona vaccine criticism

U.S. Health Policy Shifts Gears: Kennedy Jr. Initiates a Pivotal Moment with His Critique on Corona Vaccines

In a series of shake-ups within the Centers for Disease Control and Prevention (CDC) and the broader healthcare sector, a new working group has been established to evaluate COVID-19 vaccines and coordinate with the Food and Drug Administration (FDA).

The group, led by Retsef Levi, has been tasked with investigating knowledge gaps related to the distribution, pharmacokinetics, and persistence of the spike protein, mRNA, and lipid nanoparticles. They will also focus on acknowledging vaccine injuries and people who have been harmed by vaccines.

The new working group's remit extends to addressing potential contaminants such as DNA contamination, the effects of repeated booster doses on the immune system, and the impact of COVID-19 vaccines on overall mortality and hospital stays.

The appointment of Levi, who has previously called for the suspension of Pfizer and Moderna's COVID-19 vaccines due to safety and efficacy concerns, has raised eyebrows. However, it's important to note that this is a change in direction, with the group's mandate being to promote more transparency and disclosure.

The move comes after the dismissal of Susan Monarez, the director of the CDC, by Donald Trump in August 2022. Monarez was fired due to what Trump described as unscientific and reckless instructions and the dismissal of engaged health experts.

Trump's actions were not limited to the CDC. In June 2022, he dismissed all 17 voting members of the Advisory Committee on Immunization Practices (ACIP) to restore trust in vaccine science and eliminate conflicts of interest. Robert F. Kennedy Jr., a vocal critic of the CDC, spearheaded this move.

Kennedy Jr. has been a constant critic of the CDC, accusing it of becoming a bureaucratic structure that prioritises financial interests over the health of the population. He has also faced criticism and calls for resignation from political figures and current and former employees of the Department of Health and Human Services (HHS).

However, Trump's administration has also had successes in the fight against COVID-19. In August 2022, he praised "Operation Warp Speed," a public-private partnership launched by the US government in May 2020 to accelerate the development, manufacturing, and distribution of vaccines against the coronavirus.

Trump's promises to investigate the origin of the pathogen have not yet yielded definitive results. Emails from Anthony Fauci dating back to early 2020 revealed discussions on the possibility of a lab accident in Wuhan, but no public conclusion has been released by the US government up to the latest reporting date in 2025.

In a departure from his critical stance towards the CDC, Trump has also called for a return of the organisation to its core mission. This includes better monitoring of infectious diseases, building robust national and global systems, investing in the training of epidemiologists, strict scientific standards for vaccine recommendations, and strengthening local health departments.

Meanwhile, Jay Bhattacharya, director of the National Institutes of Health (NIH), has criticised COVID-19 measures as "the biggest mistake we've ever made." While Trump has questioned the success of COVID-19 vaccines and demanded clarification from pharmaceutical companies, other figures such as virologist and mRNA technology pioneer Robert Malone have joined the American equivalent of the STIKO to help guide the nation's response to the pandemic.

As the world continues to grapple with the ongoing COVID-19 pandemic, these changes within the US healthcare sector promise to bring fresh perspectives and renewed focus to the fight against the virus.

Read also: